Bridgewater Associates - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 271 filers reported holding HAEMONETICS CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bridgewater Associates ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$5,388,416
+14.7%
60,152
+9.0%
0.03%
+13.8%
Q2 2023$4,699,302
-7.9%
55,195
-10.4%
0.03%
-6.5%
Q1 2023$5,099,800
+8.9%
61,629
+3.5%
0.03%
+19.2%
Q4 2022$4,681,799
-21.9%
59,527
-26.5%
0.03%
-13.3%
Q3 2022$5,995,000
+13.5%
80,981
-0.1%
0.03%
+36.4%
Q2 2022$5,283,000
+13.7%
81,045
+10.3%
0.02%
+15.8%
Q1 2022$4,646,000
+56.5%
73,493
+31.3%
0.02%
+11.8%
Q4 2021$2,969,000
-11.8%
55,975
+17.4%
0.02%
-5.6%
Q3 2021$3,365,000
-2.7%
47,669
-8.2%
0.02%
-18.2%
Q2 2021$3,459,00051,9050.02%
Other shareholders
HAEMONETICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders